NorthWest Biotherapeutics Inc (NWBO)

[Investor082]

They will dangle more carrots! They had a ton of time to prepare for NICE evidence since TLD release in May 2022. They should have submitted NICE evidence in parallel with MHRA application in Dec 2023 or soon thereafter in Q1 2024. All they had to do was hire another set of consultants for NICE reimbursement justification alongside MHRA consultants they hired in 2022 and 2023. They didn’t do that in 2022 or 2023. That tells you all need to know.

The fact that LP finally said they roped in consultants for NICE in Q3, 2024 also provides some clue that the big pharma is not interested in commercializing L. So LP is forced to go alone. Not good either way!